Genetics, stem cells and consistent dividends can offset the problems of expiring patents
Pharmaceuticals giant AstraZeneca is to cut 700 jobs in the UK over the next three years and invest £330 million.
Advertising chief heads for fresh battle with shareholders over his pay packet
Shares in the chip-maker ARM Holdings have been much in demand in recent weeks after rumours of a potential takeover resurfaced. That chat, along with a good contract win with Samsung, almost sent the Cambridge-based company's shares to an eight-year high in September.